What is MDMA?

MDMA is a synthetic drug that significantly alters mood and perception. It is classified as a stimulant and a psychedelic by the Government of Alberta and is known for its significant empathogenic effects.

Therapeutic use of MDMA

In therapeutic settings, MDMA is used to facilitate the exploration of deeply rooted trauma and complex and challenging relationship issues where traditional approaches have not worked. MDMA-assisted sessions usually involve two to three sessions where the patient takes MDMA under the guidance of trained practitioners. Before, in between and after the sessions, therapists continue the work to integrate the learnings acquired during the sessions.

Who could benefit from MDMA therapy?

MDMA therapy is typically used for individuals with PTSD and C-PTSD, especially those who have not responded to traditional treatments. MDMA may also be beneficial for individuals with severe anxiety disorders or depression, primarily when these conditions are related to trauma or abuse.


MDMA’s ability to reduce fear and defensiveness, enhance empathy and communication, and promote feelings of emotional closeness makes it a valuable tool in therapy, particularly for individuals with PTSD who may struggle to engage in traditional talk therapy. Backed by significant clinical research and trials, MDMA allows clients to access thoughts and feelings without becoming dissociated or experiencing re-traumatization. Extreme care must be exercised during MDMA sessions, as the risk of transference and broken boundaries is enhanced.

How long are MDMA sessions?

Depending on the individual, each MDMA session lasts approximately 4-6 hours. Some clients find relief after only one session, while others require between two and three sessions spread out over several months. Integration with a therapist is essential to realize the full potential of MDMA.

What approach does The Sitting Room take with regard to MDMA?

The Psychedelic Practitioners at The Sitting Room support clients through their MDMA experience using a client-centred, supportive and compassionate approach. Using legally acquired MDMA under the authority of our Medical Director, clients are supported by two highly trained practitioners throughout the session. We spend significant time both preparing for and de-briefing the experience. We always provide the client with a confidential summary of their session insights so that if they choose, they can share their notes with their therapist. With the client’s permission, we work collaboratively with our Medical Director, Dr. Krista Leicht and the client’s therapist, to support the integration process. (Coming Fall 2024)